In addition to cutting U.S. stocks to neutral, strategists lifted Japan equities to overweight, citing underperformance in 2025 and those stocks pricing in a more bearish outcome on earnings than ...

M, consensus $627.1M. Sees FY25 gross margin 55%-56%. The company said, “This guidance is expressed in good faith and is based on management’s current view of anticipated results on a pro forma basis.

Research analysts at Roth Capital raised their Q1 2025 earnings per share (EPS) estimates for shares of Stardust Power in a ...

Investment analysts at Roth Capital lifted their Q1 2025 EPS estimates for shares of Contango Ore in a report issued on ...

Youpa Stein writes, The presence of unbound styrene in the containers, the ability of this styrene to contaminate food, and the documented hazards of styrene exposure provide compelling reasons to use ...

cut its year-end index target to 6,400 from 6,600 even as it holds an ‘attractive’ view on US equities. UBS also lowered its 2025 earnings per share (EPS) estimate for the S&P 500 to $265 from ...

Relmada Therapeutics Inc. reported its fourth-quarter 2024 earnings, showing a net loss per share of $0.62, an improvement from the previous year’s $0.84 loss per share. The company’s stock responded ...

The net sales missed the consensus mark but grew on a year-over-year basis. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. The quarter’s results were driven by strong ...

MillerKnoll, Inc. Price, Consensus and EPS Surprise MillerKnoll, Inc. Price, Consensus and EPS Surprise MillerKnoll, Inc. price-consensus-eps-surprise-chart | MillerKnoll, Inc. Quote Net sales of ...